Marketing-authorisation holder · United States
Orbion Pharms
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| GEMIFLOXACIN MESYLATE320mg base · Tablet | Gemifloxacin | United States | Not marketed | 2015 |
| IBANDRONATE SODIUM150mg base | 2.5mg · Tablet | Ibandronic acid | United States | Marketed | 2011 |
| MODAFINIL100mg | 200mg · Tablet | Modafinil | United States | Marketed | 2004 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 3 | 3 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.